Volker Schulz

Title: Volker Schulz: Innovator in Pharmaceutical Formulations

Introduction

Volker Schulz is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of gastrointestinal disorders. His innovative approach has led to the development of specialized formulations that utilize unique compounds for effective treatment.

Latest Patents

Volker Schulz holds a patent for a formulation that includes special 1,2-diacylglycero-3-phosphocholines. This patent focuses on pharmaceutical formulations designed for the treatment of gastrointestinal disorders. The active component in these formulations is an effective gastrointestinal disorder alleviating amount of a 1,2-diacylglycero-3-phosphocholine, where 75-86% by weight of the acyl radicals are unsaturated fatty acid radicals with chain lengths of 16, 18, or 20 carbon atoms. The mixtures of fatty acid radicals in the acyl groups in the 1- and 2-positions preferably have different compositions. Additionally, these formulations can contain other active compounds, particularly those that may cause injurious gastrointestinal side effects.

Career Highlights

Volker Schulz is associated with A. Nattermann & Cie GmbH, where he has been able to apply his expertise in pharmaceutical formulations. His work has been instrumental in advancing the understanding and treatment of gastrointestinal disorders through innovative formulations.

Collaborations

Volker has collaborated with notable colleagues such as Sigurd Leyck and Manfred Durr. Their combined efforts have contributed to the development of effective pharmaceutical solutions.

Conclusion

Volker Schulz's contributions to pharmaceutical formulations highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the treatment of gastrointestinal disorders, showcasing the importance of research and development in the pharmaceutical industry.